TABLE-Hollis-Eden Pharmaceuticals Q2 loss narrows

Aug 3 (Reuters) -

HOLLIS-EDEN PHARMACEUTICALS INC. (HEPH.O)
(in $) Latest Yr-ago qtr
Loss/shr (diluted) 0.20 0.33
Net Loss (million) 5.8 8.1
Total Research and
Development

expenses (million) 4.6 6.6
Reuters Estimates: Loss/shr $0.19 (one analyst).
(Reporting by Ramya Dilip in Bangalore)